World Journal of Surgical Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2151353, encodeId=f42b2151353a4, content=偏重的研究方向：临床研究;胃肠肿瘤 经验分享：除了版面费贵以外，其他方面投稿过程非常顺利，最搞笑的是不要我做好的组合图，要一张一张的原图，结果光图片就三十几张，最让我满意的proofing太仔细了，点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:12:30 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2150352, encodeId=435a2150352a3, content=送外审了以后录用的几率大么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Jul 29 09:32:19 CST 2023, time=2023-07-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2089256, encodeId=a11d2089256aa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个杂志是不要付完钱才会proof和online，急问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7fa6150272, createdName=ms2000001401387191, createdTime=Tue Sep 20 08:56:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145381, encodeId=c18e21453819b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;胃癌 经验分享：胃癌article，经历3次返修后接收后接收，历时整4月。编辑、审稿人比较友好，问的问题也很深，挺专业的。想问下是交费后才会发proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jun 29 08:57:30 CST 2023, time=2023-06-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2144749, encodeId=d8fc2144e4914, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2月1日投稿5月25日修回，6月14日接受。三个审稿人，其中一个说了很多，就一点加上影像学的资料，说明情况未加，其余就是格式语言方面的要求，修改后就接受了。版面费有些小贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97ae1333459, createdName=zhengjie9803, createdTime=Mon Jun 26 08:23:33 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236059, encodeId=26ef123605938, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：从frontiers in oncology拒稿后转投WJSO。7.22投稿case report，7.26就显示有一位审稿人审稿，7.29审稿人accepted，是不是太快了？太快了反而不太好呢？我有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/8q8mFhTIjYzR9CG5OAnicM27XgcyqWAkNupK4ibZHgCvnwWGRW8O6yPHIiciaOdAGYr75suaBQgdZk3XNxKCzCkIicw/0, createdBy=bc562172913, createdName=doctorjohnlee, createdTime=Mon Aug 01 22:50:20 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102830, encodeId=b1d12102830ec, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：外科 经验分享：外科解剖变异case，1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=034b5499641, createdName=ms4000001321333777, createdTime=Sun Nov 27 01:24:31 CST 2022, time=2022-11-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126111, encodeId=1e9321261113d, content=审稿速度快，给的意见都很中肯，虽然被拒了，以后还会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5ea8261020, createdName=ms9000001886854059, createdTime=Sat Apr 15 19:23:48 CST 2023, time=2023-04-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124491, encodeId=2806212449115, content=投稿是不是要先登录research square上才能投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Sat Apr 08 20:42:35 CST 2023, time=2023-04-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120426, encodeId=b2da2120426f7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：胃癌相关临床研究，找了两个审稿人，一个提了比较专业的意见，一个小意见，编辑给拒了，说可以修改后重投，看到评论有些说重投后也是直接拒了。想问问各位重投后拒稿几率很大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48315192002, createdName=1471bb68m86暂无昵称, createdTime=Sun Mar 19 14:33:42 CST 2023, time=2023-03-19, status=1, ipAttribution=湖北省)]

2023-08-05 shademei 来自河北省

偏重的研究方向：临床研究;胃肠肿瘤
经验分享：除了版面费贵以外，其他方面投稿过程非常顺利，最搞笑的是不要我做好的组合图，要一张一张的原图，结果光图片就三十几张，最让我满意的proofing太仔细了，点赞

36 0

[GetPortalCommentsPageByObjectIdResponse(id=2151353, encodeId=f42b2151353a4, content=偏重的研究方向：临床研究;胃肠肿瘤 经验分享：除了版面费贵以外，其他方面投稿过程非常顺利，最搞笑的是不要我做好的组合图，要一张一张的原图，结果光图片就三十几张，最让我满意的proofing太仔细了，点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:12:30 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2150352, encodeId=435a2150352a3, content=送外审了以后录用的几率大么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Jul 29 09:32:19 CST 2023, time=2023-07-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2089256, encodeId=a11d2089256aa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个杂志是不要付完钱才会proof和online，急问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7fa6150272, createdName=ms2000001401387191, createdTime=Tue Sep 20 08:56:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145381, encodeId=c18e21453819b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;胃癌 经验分享：胃癌article，经历3次返修后接收后接收，历时整4月。编辑、审稿人比较友好，问的问题也很深，挺专业的。想问下是交费后才会发proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jun 29 08:57:30 CST 2023, time=2023-06-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2144749, encodeId=d8fc2144e4914, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2月1日投稿5月25日修回，6月14日接受。三个审稿人，其中一个说了很多，就一点加上影像学的资料，说明情况未加，其余就是格式语言方面的要求，修改后就接受了。版面费有些小贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97ae1333459, createdName=zhengjie9803, createdTime=Mon Jun 26 08:23:33 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236059, encodeId=26ef123605938, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：从frontiers in oncology拒稿后转投WJSO。7.22投稿case report，7.26就显示有一位审稿人审稿，7.29审稿人accepted，是不是太快了？太快了反而不太好呢？我有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/8q8mFhTIjYzR9CG5OAnicM27XgcyqWAkNupK4ibZHgCvnwWGRW8O6yPHIiciaOdAGYr75suaBQgdZk3XNxKCzCkIicw/0, createdBy=bc562172913, createdName=doctorjohnlee, createdTime=Mon Aug 01 22:50:20 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102830, encodeId=b1d12102830ec, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：外科 经验分享：外科解剖变异case，1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=034b5499641, createdName=ms4000001321333777, createdTime=Sun Nov 27 01:24:31 CST 2022, time=2022-11-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126111, encodeId=1e9321261113d, content=审稿速度快，给的意见都很中肯，虽然被拒了，以后还会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5ea8261020, createdName=ms9000001886854059, createdTime=Sat Apr 15 19:23:48 CST 2023, time=2023-04-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124491, encodeId=2806212449115, content=投稿是不是要先登录research square上才能投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Sat Apr 08 20:42:35 CST 2023, time=2023-04-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120426, encodeId=b2da2120426f7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：胃癌相关临床研究，找了两个审稿人，一个提了比较专业的意见，一个小意见，编辑给拒了，说可以修改后重投，看到评论有些说重投后也是直接拒了。想问问各位重投后拒稿几率很大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48315192002, createdName=1471bb68m86暂无昵称, createdTime=Sun Mar 19 14:33:42 CST 2023, time=2023-03-19, status=1, ipAttribution=湖北省)]

2023-07-29 ms2000002077912665 来自北京

送外审了以后录用的几率大么

38 0

[GetPortalCommentsPageByObjectIdResponse(id=2151353, encodeId=f42b2151353a4, content=偏重的研究方向：临床研究;胃肠肿瘤 经验分享：除了版面费贵以外，其他方面投稿过程非常顺利，最搞笑的是不要我做好的组合图，要一张一张的原图，结果光图片就三十几张，最让我满意的proofing太仔细了，点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:12:30 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2150352, encodeId=435a2150352a3, content=送外审了以后录用的几率大么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Jul 29 09:32:19 CST 2023, time=2023-07-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2089256, encodeId=a11d2089256aa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个杂志是不要付完钱才会proof和online，急问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7fa6150272, createdName=ms2000001401387191, createdTime=Tue Sep 20 08:56:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145381, encodeId=c18e21453819b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;胃癌 经验分享：胃癌article，经历3次返修后接收后接收，历时整4月。编辑、审稿人比较友好，问的问题也很深，挺专业的。想问下是交费后才会发proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jun 29 08:57:30 CST 2023, time=2023-06-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2144749, encodeId=d8fc2144e4914, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2月1日投稿5月25日修回，6月14日接受。三个审稿人，其中一个说了很多，就一点加上影像学的资料，说明情况未加，其余就是格式语言方面的要求，修改后就接受了。版面费有些小贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97ae1333459, createdName=zhengjie9803, createdTime=Mon Jun 26 08:23:33 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236059, encodeId=26ef123605938, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：从frontiers in oncology拒稿后转投WJSO。7.22投稿case report，7.26就显示有一位审稿人审稿，7.29审稿人accepted，是不是太快了？太快了反而不太好呢？我有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/8q8mFhTIjYzR9CG5OAnicM27XgcyqWAkNupK4ibZHgCvnwWGRW8O6yPHIiciaOdAGYr75suaBQgdZk3XNxKCzCkIicw/0, createdBy=bc562172913, createdName=doctorjohnlee, createdTime=Mon Aug 01 22:50:20 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102830, encodeId=b1d12102830ec, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：外科 经验分享：外科解剖变异case，1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=034b5499641, createdName=ms4000001321333777, createdTime=Sun Nov 27 01:24:31 CST 2022, time=2022-11-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126111, encodeId=1e9321261113d, content=审稿速度快，给的意见都很中肯，虽然被拒了，以后还会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5ea8261020, createdName=ms9000001886854059, createdTime=Sat Apr 15 19:23:48 CST 2023, time=2023-04-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124491, encodeId=2806212449115, content=投稿是不是要先登录research square上才能投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Sat Apr 08 20:42:35 CST 2023, time=2023-04-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120426, encodeId=b2da2120426f7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：胃癌相关临床研究，找了两个审稿人，一个提了比较专业的意见，一个小意见，编辑给拒了，说可以修改后重投，看到评论有些说重投后也是直接拒了。想问问各位重投后拒稿几率很大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48315192002, createdName=1471bb68m86暂无昵称, createdTime=Sun Mar 19 14:33:42 CST 2023, time=2023-03-19, status=1, ipAttribution=湖北省)]

2022-09-20 ms2000001401387191

审稿速度:2.0 | 投稿命中率:75.0
经验分享：这个杂志是不要付完钱才会proof和online，急问

84 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151353, encodeId=f42b2151353a4, content=偏重的研究方向：临床研究;胃肠肿瘤 经验分享：除了版面费贵以外，其他方面投稿过程非常顺利，最搞笑的是不要我做好的组合图，要一张一张的原图，结果光图片就三十几张，最让我满意的proofing太仔细了，点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:12:30 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2150352, encodeId=435a2150352a3, content=送外审了以后录用的几率大么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Jul 29 09:32:19 CST 2023, time=2023-07-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2089256, encodeId=a11d2089256aa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个杂志是不要付完钱才会proof和online，急问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7fa6150272, createdName=ms2000001401387191, createdTime=Tue Sep 20 08:56:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145381, encodeId=c18e21453819b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;胃癌 经验分享：胃癌article，经历3次返修后接收后接收，历时整4月。编辑、审稿人比较友好，问的问题也很深，挺专业的。想问下是交费后才会发proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jun 29 08:57:30 CST 2023, time=2023-06-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2144749, encodeId=d8fc2144e4914, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2月1日投稿5月25日修回，6月14日接受。三个审稿人，其中一个说了很多，就一点加上影像学的资料，说明情况未加，其余就是格式语言方面的要求，修改后就接受了。版面费有些小贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97ae1333459, createdName=zhengjie9803, createdTime=Mon Jun 26 08:23:33 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236059, encodeId=26ef123605938, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：从frontiers in oncology拒稿后转投WJSO。7.22投稿case report，7.26就显示有一位审稿人审稿，7.29审稿人accepted，是不是太快了？太快了反而不太好呢？我有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/8q8mFhTIjYzR9CG5OAnicM27XgcyqWAkNupK4ibZHgCvnwWGRW8O6yPHIiciaOdAGYr75suaBQgdZk3XNxKCzCkIicw/0, createdBy=bc562172913, createdName=doctorjohnlee, createdTime=Mon Aug 01 22:50:20 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102830, encodeId=b1d12102830ec, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：外科 经验分享：外科解剖变异case，1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=034b5499641, createdName=ms4000001321333777, createdTime=Sun Nov 27 01:24:31 CST 2022, time=2022-11-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126111, encodeId=1e9321261113d, content=审稿速度快，给的意见都很中肯，虽然被拒了，以后还会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5ea8261020, createdName=ms9000001886854059, createdTime=Sat Apr 15 19:23:48 CST 2023, time=2023-04-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124491, encodeId=2806212449115, content=投稿是不是要先登录research square上才能投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Sat Apr 08 20:42:35 CST 2023, time=2023-04-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120426, encodeId=b2da2120426f7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：胃癌相关临床研究，找了两个审稿人，一个提了比较专业的意见，一个小意见，编辑给拒了，说可以修改后重投，看到评论有些说重投后也是直接拒了。想问问各位重投后拒稿几率很大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48315192002, createdName=1471bb68m86暂无昵称, createdTime=Sun Mar 19 14:33:42 CST 2023, time=2023-03-19, status=1, ipAttribution=湖北省)]

2023-06-29 ms9000001935138113 来自北京

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;胃癌
经验分享：胃癌article，经历3次返修后接收后接收，历时整4月。编辑、审稿人比较友好，问的问题也很深，挺专业的。想问下是交费后才会发proof吗？

27 0

[GetPortalCommentsPageByObjectIdResponse(id=2151353, encodeId=f42b2151353a4, content=偏重的研究方向：临床研究;胃肠肿瘤 经验分享：除了版面费贵以外，其他方面投稿过程非常顺利，最搞笑的是不要我做好的组合图，要一张一张的原图，结果光图片就三十几张，最让我满意的proofing太仔细了，点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:12:30 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2150352, encodeId=435a2150352a3, content=送外审了以后录用的几率大么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Jul 29 09:32:19 CST 2023, time=2023-07-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2089256, encodeId=a11d2089256aa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个杂志是不要付完钱才会proof和online，急问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7fa6150272, createdName=ms2000001401387191, createdTime=Tue Sep 20 08:56:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145381, encodeId=c18e21453819b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;胃癌 经验分享：胃癌article，经历3次返修后接收后接收，历时整4月。编辑、审稿人比较友好，问的问题也很深，挺专业的。想问下是交费后才会发proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jun 29 08:57:30 CST 2023, time=2023-06-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2144749, encodeId=d8fc2144e4914, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2月1日投稿5月25日修回，6月14日接受。三个审稿人，其中一个说了很多，就一点加上影像学的资料，说明情况未加，其余就是格式语言方面的要求，修改后就接受了。版面费有些小贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97ae1333459, createdName=zhengjie9803, createdTime=Mon Jun 26 08:23:33 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236059, encodeId=26ef123605938, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：从frontiers in oncology拒稿后转投WJSO。7.22投稿case report，7.26就显示有一位审稿人审稿，7.29审稿人accepted，是不是太快了？太快了反而不太好呢？我有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/8q8mFhTIjYzR9CG5OAnicM27XgcyqWAkNupK4ibZHgCvnwWGRW8O6yPHIiciaOdAGYr75suaBQgdZk3XNxKCzCkIicw/0, createdBy=bc562172913, createdName=doctorjohnlee, createdTime=Mon Aug 01 22:50:20 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102830, encodeId=b1d12102830ec, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：外科 经验分享：外科解剖变异case，1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=034b5499641, createdName=ms4000001321333777, createdTime=Sun Nov 27 01:24:31 CST 2022, time=2022-11-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126111, encodeId=1e9321261113d, content=审稿速度快，给的意见都很中肯，虽然被拒了，以后还会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5ea8261020, createdName=ms9000001886854059, createdTime=Sat Apr 15 19:23:48 CST 2023, time=2023-04-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124491, encodeId=2806212449115, content=投稿是不是要先登录research square上才能投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Sat Apr 08 20:42:35 CST 2023, time=2023-04-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120426, encodeId=b2da2120426f7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：胃癌相关临床研究，找了两个审稿人，一个提了比较专业的意见，一个小意见，编辑给拒了，说可以修改后重投，看到评论有些说重投后也是直接拒了。想问问各位重投后拒稿几率很大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48315192002, createdName=1471bb68m86暂无昵称, createdTime=Sun Mar 19 14:33:42 CST 2023, time=2023-03-19, status=1, ipAttribution=湖北省)]

2023-06-26 zhengjie9803 来自湖北省

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤
经验分享：2月1日投稿5月25日修回，6月14日接受。三个审稿人，其中一个说了很多，就一点加上影像学的资料，说明情况未加，其余就是格式语言方面的要求，修改后就接受了。版面费有些小贵。

29 0

[GetPortalCommentsPageByObjectIdResponse(id=2151353, encodeId=f42b2151353a4, content=偏重的研究方向：临床研究;胃肠肿瘤 经验分享：除了版面费贵以外，其他方面投稿过程非常顺利，最搞笑的是不要我做好的组合图，要一张一张的原图，结果光图片就三十几张，最让我满意的proofing太仔细了，点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:12:30 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2150352, encodeId=435a2150352a3, content=送外审了以后录用的几率大么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Jul 29 09:32:19 CST 2023, time=2023-07-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2089256, encodeId=a11d2089256aa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个杂志是不要付完钱才会proof和online，急问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7fa6150272, createdName=ms2000001401387191, createdTime=Tue Sep 20 08:56:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145381, encodeId=c18e21453819b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;胃癌 经验分享：胃癌article，经历3次返修后接收后接收，历时整4月。编辑、审稿人比较友好，问的问题也很深，挺专业的。想问下是交费后才会发proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jun 29 08:57:30 CST 2023, time=2023-06-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2144749, encodeId=d8fc2144e4914, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2月1日投稿5月25日修回，6月14日接受。三个审稿人，其中一个说了很多，就一点加上影像学的资料，说明情况未加，其余就是格式语言方面的要求，修改后就接受了。版面费有些小贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97ae1333459, createdName=zhengjie9803, createdTime=Mon Jun 26 08:23:33 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236059, encodeId=26ef123605938, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：从frontiers in oncology拒稿后转投WJSO。7.22投稿case report，7.26就显示有一位审稿人审稿，7.29审稿人accepted，是不是太快了？太快了反而不太好呢？我有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/8q8mFhTIjYzR9CG5OAnicM27XgcyqWAkNupK4ibZHgCvnwWGRW8O6yPHIiciaOdAGYr75suaBQgdZk3XNxKCzCkIicw/0, createdBy=bc562172913, createdName=doctorjohnlee, createdTime=Mon Aug 01 22:50:20 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102830, encodeId=b1d12102830ec, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：外科 经验分享：外科解剖变异case，1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=034b5499641, createdName=ms4000001321333777, createdTime=Sun Nov 27 01:24:31 CST 2022, time=2022-11-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126111, encodeId=1e9321261113d, content=审稿速度快，给的意见都很中肯，虽然被拒了，以后还会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5ea8261020, createdName=ms9000001886854059, createdTime=Sat Apr 15 19:23:48 CST 2023, time=2023-04-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124491, encodeId=2806212449115, content=投稿是不是要先登录research square上才能投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Sat Apr 08 20:42:35 CST 2023, time=2023-04-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120426, encodeId=b2da2120426f7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：胃癌相关临床研究，找了两个审稿人，一个提了比较专业的意见，一个小意见，编辑给拒了，说可以修改后重投，看到评论有些说重投后也是直接拒了。想问问各位重投后拒稿几率很大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48315192002, createdName=1471bb68m86暂无昵称, createdTime=Sun Mar 19 14:33:42 CST 2023, time=2023-03-19, status=1, ipAttribution=湖北省)]

2022-08-01 doctorjohnlee

审稿速度:1.0 | 投稿命中率:50.0
经验分享：从frontiers in oncology拒稿后转投WJSO。7.22投稿case report，7.26就显示有一位审稿人审稿，7.29审稿人accepted，是不是太快了？太快了反而不太好呢？我有点慌

52 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151353, encodeId=f42b2151353a4, content=偏重的研究方向：临床研究;胃肠肿瘤 经验分享：除了版面费贵以外，其他方面投稿过程非常顺利，最搞笑的是不要我做好的组合图，要一张一张的原图，结果光图片就三十几张，最让我满意的proofing太仔细了，点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:12:30 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2150352, encodeId=435a2150352a3, content=送外审了以后录用的几率大么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Jul 29 09:32:19 CST 2023, time=2023-07-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2089256, encodeId=a11d2089256aa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个杂志是不要付完钱才会proof和online，急问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7fa6150272, createdName=ms2000001401387191, createdTime=Tue Sep 20 08:56:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145381, encodeId=c18e21453819b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;胃癌 经验分享：胃癌article，经历3次返修后接收后接收，历时整4月。编辑、审稿人比较友好，问的问题也很深，挺专业的。想问下是交费后才会发proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jun 29 08:57:30 CST 2023, time=2023-06-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2144749, encodeId=d8fc2144e4914, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2月1日投稿5月25日修回，6月14日接受。三个审稿人，其中一个说了很多，就一点加上影像学的资料，说明情况未加，其余就是格式语言方面的要求，修改后就接受了。版面费有些小贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97ae1333459, createdName=zhengjie9803, createdTime=Mon Jun 26 08:23:33 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236059, encodeId=26ef123605938, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：从frontiers in oncology拒稿后转投WJSO。7.22投稿case report，7.26就显示有一位审稿人审稿，7.29审稿人accepted，是不是太快了？太快了反而不太好呢？我有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/8q8mFhTIjYzR9CG5OAnicM27XgcyqWAkNupK4ibZHgCvnwWGRW8O6yPHIiciaOdAGYr75suaBQgdZk3XNxKCzCkIicw/0, createdBy=bc562172913, createdName=doctorjohnlee, createdTime=Mon Aug 01 22:50:20 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102830, encodeId=b1d12102830ec, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：外科 经验分享：外科解剖变异case，1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=034b5499641, createdName=ms4000001321333777, createdTime=Sun Nov 27 01:24:31 CST 2022, time=2022-11-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126111, encodeId=1e9321261113d, content=审稿速度快，给的意见都很中肯，虽然被拒了，以后还会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5ea8261020, createdName=ms9000001886854059, createdTime=Sat Apr 15 19:23:48 CST 2023, time=2023-04-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124491, encodeId=2806212449115, content=投稿是不是要先登录research square上才能投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Sat Apr 08 20:42:35 CST 2023, time=2023-04-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120426, encodeId=b2da2120426f7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：胃癌相关临床研究，找了两个审稿人，一个提了比较专业的意见，一个小意见，编辑给拒了，说可以修改后重投，看到评论有些说重投后也是直接拒了。想问问各位重投后拒稿几率很大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48315192002, createdName=1471bb68m86暂无昵称, createdTime=Sun Mar 19 14:33:42 CST 2023, time=2023-03-19, status=1, ipAttribution=湖北省)]

2022-11-27 ms4000001321333777 来自浙江省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：外科
经验分享：外科解剖变异case，1月接受

32 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151353, encodeId=f42b2151353a4, content=偏重的研究方向：临床研究;胃肠肿瘤 经验分享：除了版面费贵以外，其他方面投稿过程非常顺利，最搞笑的是不要我做好的组合图，要一张一张的原图，结果光图片就三十几张，最让我满意的proofing太仔细了，点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:12:30 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2150352, encodeId=435a2150352a3, content=送外审了以后录用的几率大么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Jul 29 09:32:19 CST 2023, time=2023-07-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2089256, encodeId=a11d2089256aa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个杂志是不要付完钱才会proof和online，急问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7fa6150272, createdName=ms2000001401387191, createdTime=Tue Sep 20 08:56:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145381, encodeId=c18e21453819b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;胃癌 经验分享：胃癌article，经历3次返修后接收后接收，历时整4月。编辑、审稿人比较友好，问的问题也很深，挺专业的。想问下是交费后才会发proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jun 29 08:57:30 CST 2023, time=2023-06-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2144749, encodeId=d8fc2144e4914, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2月1日投稿5月25日修回，6月14日接受。三个审稿人，其中一个说了很多，就一点加上影像学的资料，说明情况未加，其余就是格式语言方面的要求，修改后就接受了。版面费有些小贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97ae1333459, createdName=zhengjie9803, createdTime=Mon Jun 26 08:23:33 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236059, encodeId=26ef123605938, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：从frontiers in oncology拒稿后转投WJSO。7.22投稿case report，7.26就显示有一位审稿人审稿，7.29审稿人accepted，是不是太快了？太快了反而不太好呢？我有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/8q8mFhTIjYzR9CG5OAnicM27XgcyqWAkNupK4ibZHgCvnwWGRW8O6yPHIiciaOdAGYr75suaBQgdZk3XNxKCzCkIicw/0, createdBy=bc562172913, createdName=doctorjohnlee, createdTime=Mon Aug 01 22:50:20 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102830, encodeId=b1d12102830ec, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：外科 经验分享：外科解剖变异case，1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=034b5499641, createdName=ms4000001321333777, createdTime=Sun Nov 27 01:24:31 CST 2022, time=2022-11-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126111, encodeId=1e9321261113d, content=审稿速度快，给的意见都很中肯，虽然被拒了，以后还会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5ea8261020, createdName=ms9000001886854059, createdTime=Sat Apr 15 19:23:48 CST 2023, time=2023-04-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124491, encodeId=2806212449115, content=投稿是不是要先登录research square上才能投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Sat Apr 08 20:42:35 CST 2023, time=2023-04-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120426, encodeId=b2da2120426f7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：胃癌相关临床研究，找了两个审稿人，一个提了比较专业的意见，一个小意见，编辑给拒了，说可以修改后重投，看到评论有些说重投后也是直接拒了。想问问各位重投后拒稿几率很大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48315192002, createdName=1471bb68m86暂无昵称, createdTime=Sun Mar 19 14:33:42 CST 2023, time=2023-03-19, status=1, ipAttribution=湖北省)]

2023-04-15 ms9000001886854059 来自河北省

审稿速度快，给的意见都很中肯，虽然被拒了，以后还会再投

32 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151353, encodeId=f42b2151353a4, content=偏重的研究方向：临床研究;胃肠肿瘤 经验分享：除了版面费贵以外，其他方面投稿过程非常顺利，最搞笑的是不要我做好的组合图，要一张一张的原图，结果光图片就三十几张，最让我满意的proofing太仔细了，点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:12:30 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2150352, encodeId=435a2150352a3, content=送外审了以后录用的几率大么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Jul 29 09:32:19 CST 2023, time=2023-07-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2089256, encodeId=a11d2089256aa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个杂志是不要付完钱才会proof和online，急问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7fa6150272, createdName=ms2000001401387191, createdTime=Tue Sep 20 08:56:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145381, encodeId=c18e21453819b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;胃癌 经验分享：胃癌article，经历3次返修后接收后接收，历时整4月。编辑、审稿人比较友好，问的问题也很深，挺专业的。想问下是交费后才会发proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jun 29 08:57:30 CST 2023, time=2023-06-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2144749, encodeId=d8fc2144e4914, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2月1日投稿5月25日修回，6月14日接受。三个审稿人，其中一个说了很多，就一点加上影像学的资料，说明情况未加，其余就是格式语言方面的要求，修改后就接受了。版面费有些小贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97ae1333459, createdName=zhengjie9803, createdTime=Mon Jun 26 08:23:33 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236059, encodeId=26ef123605938, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：从frontiers in oncology拒稿后转投WJSO。7.22投稿case report，7.26就显示有一位审稿人审稿，7.29审稿人accepted，是不是太快了？太快了反而不太好呢？我有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/8q8mFhTIjYzR9CG5OAnicM27XgcyqWAkNupK4ibZHgCvnwWGRW8O6yPHIiciaOdAGYr75suaBQgdZk3XNxKCzCkIicw/0, createdBy=bc562172913, createdName=doctorjohnlee, createdTime=Mon Aug 01 22:50:20 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102830, encodeId=b1d12102830ec, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：外科 经验分享：外科解剖变异case，1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=034b5499641, createdName=ms4000001321333777, createdTime=Sun Nov 27 01:24:31 CST 2022, time=2022-11-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126111, encodeId=1e9321261113d, content=审稿速度快，给的意见都很中肯，虽然被拒了，以后还会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5ea8261020, createdName=ms9000001886854059, createdTime=Sat Apr 15 19:23:48 CST 2023, time=2023-04-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124491, encodeId=2806212449115, content=投稿是不是要先登录research square上才能投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Sat Apr 08 20:42:35 CST 2023, time=2023-04-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120426, encodeId=b2da2120426f7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：胃癌相关临床研究，找了两个审稿人，一个提了比较专业的意见，一个小意见，编辑给拒了，说可以修改后重投，看到评论有些说重投后也是直接拒了。想问问各位重投后拒稿几率很大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48315192002, createdName=1471bb68m86暂无昵称, createdTime=Sun Mar 19 14:33:42 CST 2023, time=2023-03-19, status=1, ipAttribution=湖北省)]

2023-04-08 124041f5m71(暂无昵称) 来自福建省

投稿是不是要先登录research square上才能投稿

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2151353, encodeId=f42b2151353a4, content=偏重的研究方向：临床研究;胃肠肿瘤 经验分享：除了版面费贵以外，其他方面投稿过程非常顺利，最搞笑的是不要我做好的组合图，要一张一张的原图，结果光图片就三十几张，最让我满意的proofing太仔细了，点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:12:30 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2150352, encodeId=435a2150352a3, content=送外审了以后录用的几率大么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Jul 29 09:32:19 CST 2023, time=2023-07-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2089256, encodeId=a11d2089256aa, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个杂志是不要付完钱才会proof和online，急问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7fa6150272, createdName=ms2000001401387191, createdTime=Tue Sep 20 08:56:02 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145381, encodeId=c18e21453819b, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;胃癌 经验分享：胃癌article，经历3次返修后接收后接收，历时整4月。编辑、审稿人比较友好，问的问题也很深，挺专业的。想问下是交费后才会发proof吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jun 29 08:57:30 CST 2023, time=2023-06-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2144749, encodeId=d8fc2144e4914, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2月1日投稿5月25日修回，6月14日接受。三个审稿人，其中一个说了很多，就一点加上影像学的资料，说明情况未加，其余就是格式语言方面的要求，修改后就接受了。版面费有些小贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97ae1333459, createdName=zhengjie9803, createdTime=Mon Jun 26 08:23:33 CST 2023, time=2023-06-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236059, encodeId=26ef123605938, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：从frontiers in oncology拒稿后转投WJSO。7.22投稿case report，7.26就显示有一位审稿人审稿，7.29审稿人accepted，是不是太快了？太快了反而不太好呢？我有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/8q8mFhTIjYzR9CG5OAnicM27XgcyqWAkNupK4ibZHgCvnwWGRW8O6yPHIiciaOdAGYr75suaBQgdZk3XNxKCzCkIicw/0, createdBy=bc562172913, createdName=doctorjohnlee, createdTime=Mon Aug 01 22:50:20 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102830, encodeId=b1d12102830ec, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：外科 经验分享：外科解剖变异case，1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=034b5499641, createdName=ms4000001321333777, createdTime=Sun Nov 27 01:24:31 CST 2022, time=2022-11-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126111, encodeId=1e9321261113d, content=审稿速度快，给的意见都很中肯，虽然被拒了，以后还会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5ea8261020, createdName=ms9000001886854059, createdTime=Sat Apr 15 19:23:48 CST 2023, time=2023-04-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124491, encodeId=2806212449115, content=投稿是不是要先登录research square上才能投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Sat Apr 08 20:42:35 CST 2023, time=2023-04-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120426, encodeId=b2da2120426f7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：胃癌相关临床研究，找了两个审稿人，一个提了比较专业的意见，一个小意见，编辑给拒了，说可以修改后重投，看到评论有些说重投后也是直接拒了。想问问各位重投后拒稿几率很大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48315192002, createdName=1471bb68m86暂无昵称, createdTime=Sun Mar 19 14:33:42 CST 2023, time=2023-03-19, status=1, ipAttribution=湖北省)]

2023-03-19 1471bb68m86暂无昵称来自湖北省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：临床研究
经验分享：胃癌相关临床研究，找了两个审稿人，一个提了比较专业的意见，一个小意见，编辑给拒了，说可以修改后重投，看到评论有些说重投后也是直接拒了。想问问各位重投后拒稿几率很大吗？

34 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务